Bio Pharma Engineering Limited
Company Summary
Bio Pharma Engineering Limited was set up on Friday the 29th of September 2006. Their current partial address is Clare, and the company status is Liquidation. The company's current directors have been the director of 2 other Irish companies between them. Bio Pharma Engineering Limited has 1 shareholder.
| Company Name: | Bio Pharma Engineering Limited | |
| Company Status: | LIQUIDATION | |
| RiskWatch | Form E2: Notice of Appointment of Liquidator(s) Effective Date 04/02/2026 | |
| Company Address: | Xeinadin, 50 O'Connell Street, Ennis, Clare, Ireland | |
| Telephone: | +353 (0)21 230 7120 | |
| Website: | www.biopharma.ie | |
| Key Executive: | Mr Broderick | |
| Company Size: | Log-In To View | |
| Disclaimer | Other Details | |
|---|---|---|
| Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us. | ||
Key Contact Profile
Mr Broderick is a Company Director of Bio Pharma Engineering Limited since 2025
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
Latest Updates
The latest documents filed with the Companies Registration Office for Bio Pharma Engineering Limited (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| Form B2: Change of Company Registered Office Address | 02/04/2026 | 07/05/2026 | Join Up | |
| Form B2: Change of Company Registered Office Address | 23/04/2026 | 23/04/2026 | Join Up | |
| Form B77 - Authorisation/Revocation of an Electronic Filing Agent | 01/01/2026 | 21/04/2026 | Join Up | |
| Form B77 - Authorisation/Revocation of an Electronic Filing Agent | 01/01/2026 | 21/04/2026 | Join Up | |
| Form E2: Notice of Appointment of Liquidator(s) | 04/02/2026 | 16/02/2026 | Join Up | |
| THIS COMPANY HAS 83 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
Credit Report
View the Latest Credit Report and Credit Limit on Bio Pharma Engineering Limited.
| Company Status: | Liquidation | |
| RiskWatch | Form E2: Notice of Appointment of Liquidator(s) Effective Date 04/02/2026 | |
| Latest Credit Movement: |  | |
| Date of Last Movement: | 08/03/2026 | |
| Latest Accounts Filed: | 12/08/2024 | |
| Report Based on Accounts: | 31/12/2023 | |
| Next Set of Accounts Due: | 21/12/2025 | |
| Overdue: | Yes | |
| Credit Score: | Join-Up to View | |
Full Credit Rating
To View the latest Credit Rating or Credit Limit on Bio Pharma Engineering Limited simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Directors & Owners
Satisfy due diligence requirements on Bio Pharma Engineering Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Bio Pharma Engineering Limited and Anti-Money Laundering checks (AML checks) on Bio Pharma Engineering Limited
Directors details are available to logged in users.
Ownership Structure
| Company Type: | LTD - Private Company Limited By Shares |
| Number of Shareholders: | 1 |
Compliance
Log-in now to run Due Diligence checks and Compliance checks on Bio Pharma Engineering Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
Ask Us A Question...?
More people choose Vision-net over any other search service... ask us why?
PEP and Sanctions Screening: Keeping Pace with Changing Risk
25/05/2026
PEP and sanctions screening is becoming more complex as risk evolves across markets and jurisdictions.
Fitness and Probity: Continuous Accountability
18/05/2026
Fitness and Probity has returned to the forefront in recent weeks, driven by renewed regulatory emphasis on how firms apply these standards under the Individual Accountability Framework (IAF).
AML Compliance: What Businesses Need to Be Ready For
13/05/2026
AML Compliance: What Businesses Need to Be Ready For
Risk Audit: Clearer Insight Across Your Portfolio
01/05/2026
In today's trading environment, risk rarely presents itself in a single moment. Credit profiles shift, financial resilience weakens, and company status changes can occur quietly in the background.